Further studies are necessary to determine to what extent the CagA-AKT-NFκB-DNMT1 pathway contributes to the global CpG island methylation of tumor suppressor genes in HP-associated GC in vivo and what conditions make it specific among other AKT targets. The gene discussed is S100A8; the disease is gastric cancer.